Zhenjiankang Medical (02697) has reached a strategic cooperation with the Tianjin Embodied Intelligence Innovation Center to jointly build an embodied intelligence medical industry ecosystem.
Recently, Zhen Jiankang Medical (02697) signed a strategic cooperation framework agreement with the Tianjin Embodied Intelligence Innovation Center.
Recently, Zhenjiankang Medical (02697) signed a strategic cooperation framework agreement with Tianjin Embodied Intelligence Innovation Center. The two parties will establish a long-term cooperation mechanism in the field of embodied intelligence, jointly promoting the intelligent upgrade of minimally invasive intervention therapies and the ecological construction of the embodied intelligence medical industry.
Tianjin Embodied Intelligence Innovation Center, as an innovation platform focused on the implementation of embodied intelligence scenarios and industry ecosystem building, possesses extensive cooperation resources and application scenarios. Zhenjiankang Medical has been deeply involved in the minimally invasive intervention sector for a long time. In June of this year, it made its debut on the Hong Kong Stock Exchange as the first stock of Siasun Robot & Automation for puncture surgery, becoming a pioneer and leading enterprise in the research and commercialization of percutaneous puncture surgery and ablation surgery in China. Several self-developed products have received Class III medical device registration certificates from the National Medical Products Administration, including a puncture surgery navigation and positioning system recognized as a domestic innovation, and a navigation and positioning microwave ablation system recognized as an international innovation, creating an integrated minimally invasive diagnostic and therapeutic solution for precise lesion localization and ablation treatment.
Embodied intelligence, also known as "physical AI," focuses on deeply integrating the perception, cognition, and decision-making capabilities of artificial intelligence with physical entities, enabling machines to autonomously complete complex tasks in real environments. Unlike traditional "cloud AI," embodied intelligence emphasizes a closed-loop interaction of "perception-decision-execution," which is regarded as a critical step for artificial intelligence to enter the physical world, as well as the current NEW FOCUS AUTO in global technological competition. In the medical field, the deep integration of embodied intelligence with surgical Siasun Robot & Automation is expected to transform surgical Siasun Robot & Automation from a "passive execution tool" into an "intelligent agent with real-time perception and autonomous decision-making," injecting new momentum into the precision and intelligent upgrade of minimally invasive intervention therapies.
According to the agreement, both parties will jointly tackle four main threads: Siasun Robot & Automation vision and multimodal perception, edge computing and display control synergy, artificial intelligence and scenario implementation, and collaborative industry ecosystem building. The focus will be on promoting the landing of visual-language-action (VLA) synergy in precise intervention therapies, exploring a "perception-computation-display" closed-loop solution for real-time navigation and manipulation during surgery, and constructing a full-process medical data closed loop covering pre-operative planning, intra-operative decision-making, and post-operative evaluation. Additionally, they will jointly promote standard formulation, interdisciplinary talent cultivation in medicine and engineering, and industry chain collaboration to accelerate the translation of technology from research and development to clinical practice.
This collaboration aims to deeply connect Zhenjiankang Medical's independent innovation and engineering capabilities in minimally invasive intervention and intra-operative navigation with the computing power, data, and ecological resources of Tianjin Embodied Intelligence Innovation Center, potentially opening new growth space for the intelligentization of precision intervention therapies. In the future, Zhenjiankang Medical will work hand in hand with partners to continuously promote technological co-creation and industry collaboration, building an open and win-win embodied intelligence medical industry ecosystem.
Related Articles

HK Stock Market Move | LUYUAN GP HLDG (02451) fell over 3% as it is expected that the interim profit attributable to shareholders will decline by no more than 35% year-on-year, with industry demand undergoing a cyclical adjustment.

China Galaxy Securities: The price increase trend of electronic fabrics is strong, focusing on leading companies with excellent mid-term reports.

HK Stock Market Move | CARSGEN-B (02171) rose nearly 4% again as the universal BCMA CAR-T product CT0596 was approved for clinical trials in China.
HK Stock Market Move | LUYUAN GP HLDG (02451) fell over 3% as it is expected that the interim profit attributable to shareholders will decline by no more than 35% year-on-year, with industry demand undergoing a cyclical adjustment.

China Galaxy Securities: The price increase trend of electronic fabrics is strong, focusing on leading companies with excellent mid-term reports.

HK Stock Market Move | CARSGEN-B (02171) rose nearly 4% again as the universal BCMA CAR-T product CT0596 was approved for clinical trials in China.

RECOMMEND





